Table 3. Outcome after wedge resection and segmentectomy for NSCLC.
| Author [year] | No. of patients | Stage | Compromised vs. intentional | Resection type | 5-YSR |
Local rec. rate (%) |
|||
|---|---|---|---|---|---|---|---|---|---|
| Wedge | Seg. | Wedge | Seg. | ||||||
| Miller [2002] | 25 | ≤1 cm | Compromised | Wedge: 13; Seg.: 12 | 27% | 57% | 30.8 | 8.3 | |
| Okada [2005] | 158 | IA (≤2 cm) | Mixed | Wedge: 35; Seg.: 123 | 85.7% | 96.7% | N/R | N/R | |
| El-Sherif [2007] | 81 | I | Compromised | Wedge: 55; Seg.: 26 | N/R | N/R | 14.5 | 3.8 | |
| Sienel [2008] | 87 | IA | Compromised | Wedge: 31; Seg.: 56 | 48%; cancer-related | 71%; cancer-related | 55 | 16 | |
| Koike [2014] | 328 | IA | Mixed | Wedge: 112; Seg.: 216 | 68.0%; disease-specific | 91.3%; disease-specific | 34 | 6.3 | |
NSCLC, non-small cell lung cancer; 5-YSR, 5-year survival rate; Seg., segmentectomy; N/R, not reported.